Comprehensive PANCE Examination: Advanced
Clinical Reasoning and Medical Knowledge
Assessment a well detailed one
written and graded A+ upgraded
A rigorous 150-question multiple-choice examination designed for Physician Assistant
candidates, encompassing all 15 NCCPA 2025 PANCE blueprint content categories with
emphasis on high-yield, clinically challenging scenarios requiring advanced diagnostic acumen
and evidence-based management strategies across the lifespan.
Instructions
This examination consists of 150 multiple-choice questions. Each question has four answer
options (A, B, C, D). Select the single best answer for each question. Questions are designed to
assess medical knowledge, clinical reasoning, diagnostic interpretation, and therapeutic
decision-making at an advanced level consistent with the Physician Assistant National Certifying
Examination (PANCE) standards.
Questions
Cardiovascular System (11%)
1. A 68-year-old male with a history of hypertension and type 2 diabetes presents with
progressive dyspnea on exertion, orthopnea, and peripheral edema over the past 3 weeks.
Echocardiography reveals a left ventricular ejection fraction of 35% with global hypokinesis.
His medications include lisinopril 20 mg daily, metformin 1000 mg BID, and atorvastatin 40 mg
daily. Which of the following is the most appropriate additional pharmacotherapeutic agent
to reduce his mortality risk?
A) Digoxin 0.125 mg daily
B) Spironolactone 25 mg daily
C) Diltiazem 120 mg daily
D) Hydralazine 25 mg TID
- detailed answer 100 % correct :-B
Rationale: Spironolactone, an aldosterone antagonist, is indicated for patients with New York
,Heart Association (NYHA) class III-IV heart failure with reduced ejection fraction (HFrEF) who are
already on optimal medical therapy with an ACE inhibitor and beta-blocker. It has been shown
to reduce mortality and hospitalizations. Digoxin improves symptoms but does not reduce
mortality. Diltiazem is contraindicated in HFrEF due to negative inotropic effects. Hydralazine is
used primarily in African American patients with HFrEF as adjunctive therapy.
2. A 55-year-old woman presents with acute onset of severe, tearing chest pain radiating to
her back. Her blood pressure is 190/110 mmHg in the right arm and 140/85 mmHg in the left
arm. Which of the following is the most appropriate initial imaging study?
A) Transthoracic echocardiography
B) CT angiography of the chest
C) Standard chest radiography
D) Magnetic resonance angiography
- detailed answer 100 % correct :-B
Rationale: CT angiography of the chest is the imaging modality of choice for suspected aortic
dissection due to its high sensitivity (98-100%) and specificity, rapid acquisition time, and ability
to visualize the extent of dissection and involvement of branch vessels. Transthoracic
echocardiography has limited sensitivity for aortic dissection. Chest radiography may show
mediastinal widening but is neither sensitive nor specific. Magnetic resonance angiography is
excellent but takes too long in an acute setting.
3. A 72-year-old male with known atrial fibrillation on warfarin therapy presents with acute-
onset, severe left-sided weakness, facial droop, and expressive aphasia that began 45 minutes
ago. His INR is 2.8. Head CT shows no hemorrhage. Which of the following is the most
appropriate management?
A) Administer intravenous alteplase immediately
B) Administer intravenous alteplase after reversing warfarin with fresh frozen plasma
C) Administer intravenous alteplase after reversing warfarin with vitamin K
D) Do not administer alteplase; initiate aspirin and admit for stroke evaluation
- detailed answer 100 % correct :-A
Rationale: For patients with acute ischemic stroke presenting within 4.5 hours of symptom
onset, intravenous alteplase (tPA) is indicated regardless of warfarin use if the INR is ≤1.7.
However, the American Heart Association guidelines recommend that patients on warfarin with
INR ≤1.7 may receive tPA; with INR >1.7, tPA is contraindicated. Given the INR of 2.8 in this
,patient, tPA is contraindicated. Reversing warfarin takes time and delays treatment; the patient
would not be a candidate for tPA within the therapeutic window. The correct management is to
admit, maintain supportive care, and consider mechanical thrombectomy if eligible.
4. A 45-year-old male with no significant medical history presents with palpitations,
lightheadedness, and chest discomfort. ECG demonstrates a regular, narrow-complex
tachycardia at 180 bpm with no visible P waves. Vagal maneuvers are unsuccessful. Which of
the following is the most appropriate next step?
A) Administration of intravenous adenosine 6 mg rapid push
B) Administration of intravenous amiodarone 150 mg over 10 minutes
C) Synchronized cardioversion at 100 J
D) Administration of intravenous metoprolol 5 mg
- detailed answer 100 % correct :-A
Rationale: The ECG findings are consistent with supraventricular tachycardia (SVT), most
commonly atrioventricular nodal reentrant tachycardia (AVNRT). Adenosine is the first-line
pharmacologic agent for acute termination of stable SVT due to its ultra-short half-life and high
efficacy in blocking AV nodal conduction. Amiodarone is not first-line for SVT. Synchronized
cardioversion is indicated for unstable patients. Metoprolol may be used but is not first-line and
has a slower onset.
5. A 60-year-old woman with hypertension and hyperlipidemia presents with substernal chest
pressure at rest that began 30 minutes ago. She took sublingual nitroglycerin 0.4 mg without
relief. ECG shows 2 mm ST-segment depression in leads V4-V6. Initial high-sensitivity troponin
is elevated at 85 ng/L (normal <14 ng/L). Which of the following is the most appropriate
diagnosis?
A) Unstable angina
B) ST-segment elevation myocardial infarction (STEMI)
C) Non-ST-segment elevation myocardial infarction (NSTEMI)
D) Stable angina
- detailed answer 100 % correct :-C
Rationale: This patient presents with chest pain at rest, ECG changes (ST-segment depression),
and elevated troponin, which is diagnostic of NSTEMI. Unstable angina would have normal
troponin. STEMI requires ST-segment elevation on ECG. Stable angina is precipitated by exertion
and relieved by rest.
, 6. A 28-year-old woman with no prior medical history presents with acute onset of substernal
chest pain that is worse with inspiration and improves when leaning forward. She reports a
recent upper respiratory infection. ECG shows diffuse ST-segment elevation with PR-segment
depression. Which of the following is the most likely diagnosis?
A) Acute myocardial infarction
B) Pericarditis
C) Pulmonary embolism
D) Costochondritis
- detailed answer 100 % correct :-B
Rationale: The clinical presentation of pleuritic chest pain that improves with leaning forward,
along with diffuse ST-segment elevation and PR-segment depression on ECG, is classic for acute
pericarditis, often preceded by a viral illness. Myocardial infarction would show regional ST
elevation and reciprocal changes. Pulmonary embolism typically presents with tachycardia,
hypoxia, and perhaps S1Q3T3 pattern. Costochondritis has localized chest wall tenderness
without ECG changes.
7. A 67-year-old male with a history of coronary artery disease and heart failure presents with
worsening dyspnea and fatigue. His vital signs show a blood pressure of 100/70 mmHg, heart
rate 98 bpm, and oxygen saturation 92% on room air. Jugular venous pressure is elevated at
15 cm H₂O, and he has 2+ pitting edema in both lower extremities. Echocardiogram shows an
ejection fraction of 25% with severe mitral regurgitation. Which medication class is most
likely to improve his survival?
A) Calcium channel blockers
B) Angiotensin receptor-neprilysin inhibitor (ARNI)
C) Direct-acting vasodilators
D) Phosphodiesterase-5 inhibitors
- detailed answer 100 % correct :-B
Rationale: Angiotensin receptor-neprilysin inhibitors (ARNIs), such as sacubitril/valsartan, have
been shown to significantly reduce mortality and hospitalizations in patients with HFrEF
compared to ACE inhibitors alone. The PARADIGM-HF trial demonstrated superiority of ARNI
over enalapril. Calcium channel blockers are generally avoided in HFrEF. Direct vasodilators and
PDE5 inhibitors do not have mortality benefit in this setting.
Clinical Reasoning and Medical Knowledge
Assessment a well detailed one
written and graded A+ upgraded
A rigorous 150-question multiple-choice examination designed for Physician Assistant
candidates, encompassing all 15 NCCPA 2025 PANCE blueprint content categories with
emphasis on high-yield, clinically challenging scenarios requiring advanced diagnostic acumen
and evidence-based management strategies across the lifespan.
Instructions
This examination consists of 150 multiple-choice questions. Each question has four answer
options (A, B, C, D). Select the single best answer for each question. Questions are designed to
assess medical knowledge, clinical reasoning, diagnostic interpretation, and therapeutic
decision-making at an advanced level consistent with the Physician Assistant National Certifying
Examination (PANCE) standards.
Questions
Cardiovascular System (11%)
1. A 68-year-old male with a history of hypertension and type 2 diabetes presents with
progressive dyspnea on exertion, orthopnea, and peripheral edema over the past 3 weeks.
Echocardiography reveals a left ventricular ejection fraction of 35% with global hypokinesis.
His medications include lisinopril 20 mg daily, metformin 1000 mg BID, and atorvastatin 40 mg
daily. Which of the following is the most appropriate additional pharmacotherapeutic agent
to reduce his mortality risk?
A) Digoxin 0.125 mg daily
B) Spironolactone 25 mg daily
C) Diltiazem 120 mg daily
D) Hydralazine 25 mg TID
- detailed answer 100 % correct :-B
Rationale: Spironolactone, an aldosterone antagonist, is indicated for patients with New York
,Heart Association (NYHA) class III-IV heart failure with reduced ejection fraction (HFrEF) who are
already on optimal medical therapy with an ACE inhibitor and beta-blocker. It has been shown
to reduce mortality and hospitalizations. Digoxin improves symptoms but does not reduce
mortality. Diltiazem is contraindicated in HFrEF due to negative inotropic effects. Hydralazine is
used primarily in African American patients with HFrEF as adjunctive therapy.
2. A 55-year-old woman presents with acute onset of severe, tearing chest pain radiating to
her back. Her blood pressure is 190/110 mmHg in the right arm and 140/85 mmHg in the left
arm. Which of the following is the most appropriate initial imaging study?
A) Transthoracic echocardiography
B) CT angiography of the chest
C) Standard chest radiography
D) Magnetic resonance angiography
- detailed answer 100 % correct :-B
Rationale: CT angiography of the chest is the imaging modality of choice for suspected aortic
dissection due to its high sensitivity (98-100%) and specificity, rapid acquisition time, and ability
to visualize the extent of dissection and involvement of branch vessels. Transthoracic
echocardiography has limited sensitivity for aortic dissection. Chest radiography may show
mediastinal widening but is neither sensitive nor specific. Magnetic resonance angiography is
excellent but takes too long in an acute setting.
3. A 72-year-old male with known atrial fibrillation on warfarin therapy presents with acute-
onset, severe left-sided weakness, facial droop, and expressive aphasia that began 45 minutes
ago. His INR is 2.8. Head CT shows no hemorrhage. Which of the following is the most
appropriate management?
A) Administer intravenous alteplase immediately
B) Administer intravenous alteplase after reversing warfarin with fresh frozen plasma
C) Administer intravenous alteplase after reversing warfarin with vitamin K
D) Do not administer alteplase; initiate aspirin and admit for stroke evaluation
- detailed answer 100 % correct :-A
Rationale: For patients with acute ischemic stroke presenting within 4.5 hours of symptom
onset, intravenous alteplase (tPA) is indicated regardless of warfarin use if the INR is ≤1.7.
However, the American Heart Association guidelines recommend that patients on warfarin with
INR ≤1.7 may receive tPA; with INR >1.7, tPA is contraindicated. Given the INR of 2.8 in this
,patient, tPA is contraindicated. Reversing warfarin takes time and delays treatment; the patient
would not be a candidate for tPA within the therapeutic window. The correct management is to
admit, maintain supportive care, and consider mechanical thrombectomy if eligible.
4. A 45-year-old male with no significant medical history presents with palpitations,
lightheadedness, and chest discomfort. ECG demonstrates a regular, narrow-complex
tachycardia at 180 bpm with no visible P waves. Vagal maneuvers are unsuccessful. Which of
the following is the most appropriate next step?
A) Administration of intravenous adenosine 6 mg rapid push
B) Administration of intravenous amiodarone 150 mg over 10 minutes
C) Synchronized cardioversion at 100 J
D) Administration of intravenous metoprolol 5 mg
- detailed answer 100 % correct :-A
Rationale: The ECG findings are consistent with supraventricular tachycardia (SVT), most
commonly atrioventricular nodal reentrant tachycardia (AVNRT). Adenosine is the first-line
pharmacologic agent for acute termination of stable SVT due to its ultra-short half-life and high
efficacy in blocking AV nodal conduction. Amiodarone is not first-line for SVT. Synchronized
cardioversion is indicated for unstable patients. Metoprolol may be used but is not first-line and
has a slower onset.
5. A 60-year-old woman with hypertension and hyperlipidemia presents with substernal chest
pressure at rest that began 30 minutes ago. She took sublingual nitroglycerin 0.4 mg without
relief. ECG shows 2 mm ST-segment depression in leads V4-V6. Initial high-sensitivity troponin
is elevated at 85 ng/L (normal <14 ng/L). Which of the following is the most appropriate
diagnosis?
A) Unstable angina
B) ST-segment elevation myocardial infarction (STEMI)
C) Non-ST-segment elevation myocardial infarction (NSTEMI)
D) Stable angina
- detailed answer 100 % correct :-C
Rationale: This patient presents with chest pain at rest, ECG changes (ST-segment depression),
and elevated troponin, which is diagnostic of NSTEMI. Unstable angina would have normal
troponin. STEMI requires ST-segment elevation on ECG. Stable angina is precipitated by exertion
and relieved by rest.
, 6. A 28-year-old woman with no prior medical history presents with acute onset of substernal
chest pain that is worse with inspiration and improves when leaning forward. She reports a
recent upper respiratory infection. ECG shows diffuse ST-segment elevation with PR-segment
depression. Which of the following is the most likely diagnosis?
A) Acute myocardial infarction
B) Pericarditis
C) Pulmonary embolism
D) Costochondritis
- detailed answer 100 % correct :-B
Rationale: The clinical presentation of pleuritic chest pain that improves with leaning forward,
along with diffuse ST-segment elevation and PR-segment depression on ECG, is classic for acute
pericarditis, often preceded by a viral illness. Myocardial infarction would show regional ST
elevation and reciprocal changes. Pulmonary embolism typically presents with tachycardia,
hypoxia, and perhaps S1Q3T3 pattern. Costochondritis has localized chest wall tenderness
without ECG changes.
7. A 67-year-old male with a history of coronary artery disease and heart failure presents with
worsening dyspnea and fatigue. His vital signs show a blood pressure of 100/70 mmHg, heart
rate 98 bpm, and oxygen saturation 92% on room air. Jugular venous pressure is elevated at
15 cm H₂O, and he has 2+ pitting edema in both lower extremities. Echocardiogram shows an
ejection fraction of 25% with severe mitral regurgitation. Which medication class is most
likely to improve his survival?
A) Calcium channel blockers
B) Angiotensin receptor-neprilysin inhibitor (ARNI)
C) Direct-acting vasodilators
D) Phosphodiesterase-5 inhibitors
- detailed answer 100 % correct :-B
Rationale: Angiotensin receptor-neprilysin inhibitors (ARNIs), such as sacubitril/valsartan, have
been shown to significantly reduce mortality and hospitalizations in patients with HFrEF
compared to ACE inhibitors alone. The PARADIGM-HF trial demonstrated superiority of ARNI
over enalapril. Calcium channel blockers are generally avoided in HFrEF. Direct vasodilators and
PDE5 inhibitors do not have mortality benefit in this setting.
